Edgewise Therapeutics
A Movement in Muscle
We are dedicated to transforming cardiovascular muscle diseases.
Learn More
All of us at Edgewise are committed to developing new medicines for people facing serious cardiovascular diseases with unmet medical needs.
Explore our Pipeline
Following the close of our transaction with Servier, Edgewise’s muscular dystrophy business, including sevasemten, is now part of Servier. Servier’s global capabilities and commitment to neuromuscular diseases position it to advance sevasemten and continue supporting the patient and advocacy communities we have been privileged to serve.
Edgewise is now focused exclusively on advancing high-impact therapies for people living with serious cardiovascular diseases.
Learn more
Living with a rare muscle disease
Filter Patient Stories
Living with HCM.
Patient Advocate. Author. Volunteer.
Read Lindsay's Story
Filter by:
See more patient videos here
